rs779808

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000551.4(VHL):​c.340+1150C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 151,910 control chromosomes in the GnomAD database, including 27,799 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 27799 hom., cov: 32)

Consequence

VHL
NM_000551.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.272

Publications

4 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.769 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
NM_000551.4
MANE Select
c.340+1150C>T
intron
N/ANP_000542.1
VHL
NM_001354723.2
c.*17+316C>T
intron
N/ANP_001341652.1
VHL
NM_198156.3
c.340+1150C>T
intron
N/ANP_937799.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
ENST00000256474.3
TSL:1 MANE Select
c.340+1150C>T
intron
N/AENSP00000256474.3
VHL
ENST00000345392.3
TSL:1
c.340+1150C>T
intron
N/AENSP00000344757.2
VHL
ENST00000477538.2
TSL:1
n.1220+316C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.570
AC:
86477
AN:
151792
Hom.:
27785
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.245
Gnomad AMI
AF:
0.601
Gnomad AMR
AF:
0.653
Gnomad ASJ
AF:
0.740
Gnomad EAS
AF:
0.789
Gnomad SAS
AF:
0.560
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.692
Gnomad OTH
AF:
0.606
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.570
AC:
86519
AN:
151910
Hom.:
27799
Cov.:
32
AF XY:
0.577
AC XY:
42855
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.245
AC:
10148
AN:
41368
American (AMR)
AF:
0.653
AC:
9963
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.740
AC:
2569
AN:
3470
East Asian (EAS)
AF:
0.789
AC:
4078
AN:
5168
South Asian (SAS)
AF:
0.559
AC:
2699
AN:
4828
European-Finnish (FIN)
AF:
0.760
AC:
8027
AN:
10560
Middle Eastern (MID)
AF:
0.673
AC:
198
AN:
294
European-Non Finnish (NFE)
AF:
0.692
AC:
47025
AN:
67952
Other (OTH)
AF:
0.599
AC:
1265
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1623
3246
4870
6493
8116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.610
Hom.:
3968
Bravo
AF:
0.548
Asia WGS
AF:
0.654
AC:
2274
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
4.8
DANN
Benign
0.96
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779808; hg19: chr3-10185021; API